Skip to main content
SpringerLink
Log in

ASO Author Reflections: Is Systemic Immune-Inflammation Index a Useful Biomarker After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. DeOliveira ML, Cunningham SC, Cameron JL, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245(5):755–62. https://doi.org/10.1097/01.sla.0000251366.62632.d3.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Sahara K, Tsilimigras DI, Toyoda J, et al. Defining the risk of early recurrence following curative-intent resection for distal cholangiocarcinoma. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-09811-4.

    Article  PubMed  Google Scholar 

  3. Sahara K, Tsilimigras DI, Pawlik TM. ASO Author Reflections: Development and validation of distal cholangiocarcinoma early recurrence (DICER) score: Results from the US extrahepatic biliary malignancy consortium. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-09844-9.

    Article  PubMed  Google Scholar 

  4. Tsilimigras DI, Moris D, Mehta R, et al. The systemic immune-inflammation index predicts prognosis in intrahepatic cholangiocarcinoma: an international multi-institutional analysis. HPB. 2020. https://doi.org/10.1016/j.hpb.2020.03.011.

    Article  PubMed  Google Scholar 

  5. Junya Toyoda KS, Shishir K. Maithel, Daniel E. Abbott. Prognostic utility of systemic immune-inflammation index after resection of extrahepatic cholangiocarcinoma: Results from the US Extrahepatic Biliary Malignancy Consortium. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12058-2.

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterological Surgery, Yokohama City University School of Medicine, Yokohama, Japan

    Junya Toyoda MD, Kota Sahara MD & Itaru Endo MD

  2. Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA

    Kota Sahara MD & Timothy M. Pawlik MD, PhD, MPH, MTS, MBA

Authors
  1. Junya Toyoda MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kota Sahara MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Itaru Endo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Timothy M. Pawlik MD, PhD, MPH, MTS, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Timothy M. Pawlik MD, PhD, MPH, MTS, MBA.

Ethics declarations

Disclosure

The authors have no conflicts of interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Toyoda, J., Sahara, K., Endo, I. et al. ASO Author Reflections: Is Systemic Immune-Inflammation Index a Useful Biomarker After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium. Ann Surg Oncol 29, 7615–7616 (2022). https://doi.org/10.1245/s10434-022-12105-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12105-y

Search

Navigation